3
Announcements
Trials
Browse
Landscape
Phase
Phase NA
1
Status
Completed
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Gastrointestinal
1
Conditions
Papillomavirus Infections
2
Breast Neoplasms
2
Acquired Immunodeficiency Syndrome
2
Uterine Cervical Neoplasms
1
Uterine Cervical Dysplasia
1
Sexually Transmitted Diseases
1
Lung Neoplasms
1
High-grade Anal Intraepithelial Neoplasia
1
HIV Infections
1
Condylomata Acuminata
1
Benign Ovarian Tumor
1
Anus Neoplasms
1
Interventions
Fluorouracil
14
Radiotherapy
11
Mitomycin
9
Radiation
8
Capecitabine
8
Surveys and Questionnaires
6
Drug Therapy
6
Cisplatin
6
pembrolizumab
5
Paclitaxel
4
Magnetic Resonance Spectroscopy
4
Irinotecan
3
Immune Checkpoint Inhibitors
3
Cetuximab
3
Carboplatin
3
Biopsy
3
tislelizumab
2
durvalumab
2
atezolizumab
2
aldesleukin
2
Therapeutics
2
Specimen Handling
2
Papillomavirus Vaccines
2
Oxaliplatin
2
Observation
2
Nivolumab
2
Cyclophosphamide
2
Blood Specimen Collection
2
Adoptive Transfer
2
toripalimab
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
OTHER
×
Anus Neoplasms
×
Electrocoagulation
×
Clear all
NCT02615860
2022-11-08
TECAIN
University Hospital, Essen
Phase NA
Completed
560 enrolled